PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Mutations in the PTEN induced putative kinase 1 (PINK1) gene cause an autosomal recessive form of Parkinson disease (PD). So far, no substrates of PINK1 have been reported, and the mechanism by which PINK1 mutations lead to neurodegeneration is unknown. Here we report the identification of TNF receptor-associated protein 1 (TRAP1), a mitochondrial molecular chaperone also known as heat shock protein 75 (Hsp75), as a cellular substrate for PINK1 kinase. PINK1 binds and colocalizes with TRAP1 in the mitochondria and phosphorylates TRAP1 both in vitro and in vivo. We show that PINK1 protects against oxidative-stress-induced cell death by suppressing cytochrome c release from mitochondria, and this protective action of PINK1 depends on its kinase activity to phosphorylate TRAP1. Moreover, we find that the ability of PINK1 to promote TRAP1 phosphorylation and cell survival is impaired by PD-linked PINK1 G309D, L347P, and W437X mutations. Our findings suggest a novel pathway by which PINK1 phosphorylates downstream effector TRAP1 to prevent oxidative-stress-induced apoptosis and implicate the dysregulation of this mitochondrial pathway in PD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Phosphorylation of TRAP1 by Wild-Type and Mutant PINK1 (A) In vitro kinase assays were performed by incubation of purified TRAP1 with [γ32-P] ATP in the absence (control) or presence of FLAG-tagged wild-type (WT) or mutant PINK1 proteins as indicated. Phosphorylated TRAP1 was visualized by autoradiography (top panel). PINK1 and TRAP1 proteins used in the kinase assays were shown by immunoblotting with anti-TRAP1 (middle panel) and anti-FLAG antibodies (bottom panel). (B) Normalized levels of in vitro TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± standard error of the mean (SEM) from three independent experiments. *Significantly different from the wild-type PINK1 (p < 0.01). (C) PC12 cells expressing wild-type or mutant PINK1 or vector-transfected controls were treated with 400 μM H2O2 as indicated. In vivo phosphorylation of endogenous TRAP1 was determined by immunoprecipitation with anti-TRAP1 antibody followed by immunoblotting using anti-phosphoserine (upper panel) and anti-TRAP1 (lower panel) antibodies. (D) Normalized levels of in vivo TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± SEM from three independent experiments. aSignificantly different from the corresponding H2O2-treated vector-transfected controls (p < 0.01). bSignificantly different from the wild-type PINK1-transfected cells (p < 0.01). AU, arbitrary units.](https://figures.cochat.ai/paper-figures/17d4ebdc4d0a46a99e4bb1385a64faa3/pink1-protects-against-oxidative-stress-by-phosphorylating-mitochondrial-figure-3.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Normally, PINK1 serves a protective role by helping to produce the PTEN-induced kinase protein, which shields mitochondria from damage caused by the reactive oxygen species (ROS) [140].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [140]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,911 · cited 1×
“Biochemical assays of cytochrome c release were performed as described [40].”
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · cited 2×
“served serine/threonine kinase domain [5].”
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · cited 1×
“Postmortem analyses reveal a deficiency in the mitochondrial complex I function in patients with sporadic PD [3].”
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 1×
“loss of PINK1 leads to mitochondrial defects and degeneration of muscle and dopaminergic neurons [”
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 1×
“dopaminergic neurons [17–20].”
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182 · cited 1×
“In vitro kinase assays were performed as described [33] by incubation of affinity-purified FLAG-tagged wild-type or mutant PINK1 with TRAP1 for 20 min at 30 8C in 100 ll of reaction buffer containing 50 mM Tris-HCl (pH 7.”
Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,116 · cited 1×
“PC12 cells were treated with H2O2 as indicated, and cell viability was assessed using the 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described [38].”
Modulation of neurodegeneration by molecular chaperones
Muchowski, P. J., & Wacker, J. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1587 · Cited by 1,024 · cited 1×
“of cellular processes, including cell survival and apoptosis [24, 25 ].”
Research works printed but not linked: 41
- Lang, 1998, N Engl J Med, 339, 1044
- Farrer, 2006, Nat Rev Genet, 7, 306
- Schapira, 1989, Lancet, 1, 1269
- Betarbet, 2002, Bioessays, 24, 308
- Valente, 2004, Science, 304, 1158
- Hatano, 2004, Ann Neurol, 56, 424
- Bonifati, 2005, Neurology, 65, 87
- Zadikoff, 2006, Mov Disord, 21, 875
- Hedrich, 2006, Arch Neurol, 63, 833
- Criscuolo, 2006, Mov Disord, 21, 1265
- Beilina, 2005, Proc Natl Acad Sci U S A, 102, 5703
- Silvestri, 2005, Hum Mol Genet, 14, 3477
- Gandhi, 2006, Brain, 129, 1720
- Nakajima, 2003, Cancer Lett, 201, 195
- Petit, 2005, J Biol Chem, 280, 34025
- Deng, 2005, Biochem Biophys Res Commun, 337, 1133
- Clark, 2006, Nature, 441, 1162
- Park, 2006, Nature, 441, 1157
- Wang, 2006, Proc Natl Acad Sci U S A, 103, 13520
- Yang, 2006, Proc Natl Acad Sci U S A, 103, 10793
- Song, 1995, J Biol Chem, 270, 3574
- Chen, 1996, Mol Cell Biol, 16, 4691
- Felts, 2000, J Biol Chem, 275, 3305
- Beere, 2005, J Clin Invest, 115, 2633
- Muchowski, 2005, Nat Rev Neurosci, 6, 11
- Masuda, 2004, J Biol Chem, 279, 42503
- Sim, 2006, Hum Mol Genet, 15, 3251
- Olzmann, 2004, J Biol Chem, 279, 8506
- Chin, 2000, J Biol Chem, 275, 1191
- Choi, 2004, J Biol Chem, 279, 13256
- Choi, 2006, J Biol Chem, 281, 10816
- Chin, 2001, J Biol Chem, 276, 7069
- Ninomiya-Tsuji, 1999, Nature, 398, 252
- Lewis Carl, 1993, J Histochem Cytochem, 41, 1273
- Li, 2002, J Biol Chem, 277, 28212
- Hovius, 1990, Biochim Biophys Acta, 1021, 217
- Kirk, 2006, J Cell Sci, 119, 4689
- Canet-Aviles, 2004, Proc Natl Acad Sci U S A, 101, 9103
- Chen, 2001, Proc Natl Acad Sci U S A, 98, 7783
- Yang, 1997, Science, 275, 1129
- Sherer, 2002, J Neurosci, 22, 7006
Cited by
Items 101–200 of 596
C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease
Harrington, A. J., Hamamichi, S., Caldwell, G. A., & Caldwell, K. A. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22231 · Cited by 174
“Moreover, Pridgeon et al. (2007) reported that PINK1 protects the mammalian cells from oxidative stress-induced cell death by suppressing cytochrome c release from mitochondria.”
BackgroundHsp90 Inhibition Decreases Mitochondrial Protein Turnover
Margineantu, D. H., Emerson, C. B., Diaz, D., & Hockenbery, D. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001066 · Cited by 147
“TRAP1, a mitochondrial paralog of hsp90, is also inhibited by the tested hsp90 inhibitors [36,37].”
BackgroundMitochondrial Contribution to Parkinson's Disease Pathogenesis
Schapira, A. H. V., & Gegg, M. (2011) · Parkinson's Disease · doi:10.4061/2011/159160 · Cited by 146
“The mitochondrial chaperone TRAP1 has been shown to be a direct substrate of PINK1 [112].”
BackgroundMiro phosphorylation sites regulate Parkin recruitment and mitochondrial motility
Shlevkov, E., Kramer, T., Schapansky, J., LaVoie, M. J., & Schwarz, T. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612283113 · Cited by 145
A Mitocentric View of Parkinson's Disease
Haelterman, N. A., Yoon, W. H., Sandoval, H., Jaiswal, M., Shulman, J. M., & Bellen, H. J. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014317 · Cited by 144
“This chaperone was the first in vivo target identified for Pink1, and evidence proposed that Pink1’s function in protecting the cell from ROS-induced cell death depends on Trap1 phosphorylation (Figure 1) (Pridgeon et al. 2007).”
BackgroundPositioning mitochondrial plasticity within cellular signaling cascades
Soubannier, V., & McBride, H. M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.008 · Cited by 164
“To date, two potential mitochondrial targets for PINK1 have emerged, the heat shock protein TRAP1 [220], and the serine protease Omi/HtrA2 [221].”
BackgroundWhat causes cell death in Parkinson's disease?
Gupta, A., Dawson, V. L., & Dawson, T. M. (2009) · Annals of Neurology · doi:10.1002/ana.21573 · Cited by 143
“TRAP1 and HtrA2 represent the two main PINK1 interactors that have been identified so far.(75,76) TRAP1 is a mitochondrial chaperone that is activated under oxidative stress.”
BackgroundA New Cytosolic Pathway from a Parkinson Disease-associated Kinase, BRPK/PINK1
Murata, H., Sakaguchi, M., Jin, Y., Sakaguchi, Y., Futami, J.-I., Yamada, H., Kataoka, K., & Huh, N.-H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179390 · Cited by 142
The Mitochondrial Chaperone Protein TRAP1 Mitigates α-Synuclein Toxicity
Butler, E. K., Voigt, A., Lutz, A. K., Toegel, J. P., Gerhardt, E., Karsten, P., Falkenburger, B., Reinartz, A., Winklhofer, K. F., & Schulz, J. B. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002488 · Cited by 142
“TRAP1 is a mitochondrial chaperone, recently reported as a downstream phosphorylation target of the PD protein PINK1 in rat and human cell lines [39].”
BackgroundMalkus, K. A., Tsika, E., & Ischiropoulos, H. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-24 · Cited by 142
“Protection of cellular viability was related to the ability of PINK1 to prevent loss of mitochondrial membrane potential, to suppress cytochrome c release from mitochondria, and suppress activation of caspase-3 [112,115,125,126].”
BackgroundSimunovic, F., Yi, M., Wang, Y., Stephens, R., & Sonntag, K. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008856 · Cited by 141
“Interestingly, there seems to be a connection between PINK1 and the TNF pathway, as one of PINK1’s substrates is the TNF-receptor associated protein 1 (TRAP1) [33], which was downregulated in male PD.”
BackgroundThe Chaperone TRAP1 As a Modulator of the Mitochondrial Adaptations in Cancer Cells
Masgras, I., Sanchez-Martin, C., Colombo, G., & Rasola, A. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00058 · Cited by 139
“PINK1-dependent phosphorylation leads to an increase in TRAP1 anti-oxidant function (86), even if the relevance of this PTM in tumorigenesis remains unknown.”
BackgroundEmerging functional cross-talk between the Keap1-Nrf2 system and mitochondria
Itoh, K., Ye, P., Matsumiya, T., Tanji, K., & Ozaki, T. (2015) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.14-134 · Cited by 140
Mitochondrial dynamics in Parkinson's disease
Van Laar, V. S., & Berman, S. B. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.019 · Cited by 140
“PINK1 is a mitochondrially targeted protein possessing a transmembrane domain, and it has been found localized to the inner mitochondrial membrane (Gandhi et al., 2006; Muqit et al., 2006; Pridgeon et al., 2007; Silvestri et al., 2005), the intermembrane space (Plun-Favreau et al.”
BackgroundInfluentialLoss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury
Siddall, H. K., Yellon, D. M., Ong, S.-B., Mukherjee, U. A., Burke, N., Hall, A. R., Angelova, P. R., Ludtmann, M. H. R., Deas, E., Davidson, S. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062400 · Cited by 135
“PINK1 has been reported to phosphorylate TNF receptorassociated protein 1 (TRAP1), a mitochondrial chaperone protein, which protects against oxidative stress-induced apoptotic cell death [36].”
BackgroundParkinson disease protein DJ-1 converts from a zymogen to a protease by carboxyl-terminal cleavage
Chen, J., Li, L., & Chin, L.-S. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq113 · Cited by 137
“For the analysis of apoptosis in transfected SH-SY5Y cells, transfected cells were identified by the green fluorescence emitted from co-transfected GFP expression vector and apoptotic cell death was measured by morphological assessment of nuclei stained with 4′,6-diamidino-2-phenylindole (DAPI, Molecular Probes) as de…”
MethodSelf-citationThe PINK1/Parkin pathway: a mitochondrial quality control system?
Whitworth, A. J., & Pallanck, L. J. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9253-3 · Cited by 137
Liu, W., Vives-Bauza, C., Acín-Peréz-, R., Yamamoto, A., Tan, Y., Li, Y., Magrané, J., Stavarache, M. A., Shaffer, S., Chang, S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004597 · Cited by 135
“Recent studies have begun to shed light on the mechanisms through which PINK1 causes PD, and implicate cellular functions such as mitochondrial respiration [21,22], mitochondrial morphology and dynamics [23,24,25,26,27], and oxidative stress [21,28].”
BackgroundMitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease
Calì, T., Ottolini, D., & Brini, M. (2011) · BioFactors · doi:10.1002/biof.159 · Cited by 134
Structure and Function of Parkin, PINK1, and DJ-1, the Three Musketeers of Neuroprotection
Trempe, J.-F., & Fon, E. A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00038 · Cited by 133
“Early studies identified the mitochondrial chaperone TRAP1 as a ligand and phosphorylation substrate of PINK1 (Pridgeon et al., 2007).”
BackgroundMitochondrial quality control by the Pink1/Parkin system
Rüb, C., Wilkening, A., & Voos, W. (2017) · Cell and Tissue Research · doi:10.1007/s00441-016-2485-8 · Cited by 132
“Several other phosphorylation substrates of Pink1 have been proposed, including the mitochondrial Hsp90 chaperone TRAP1 (Pridgeon et al. 2007), mitofusin 2 (Chen and Dorn 2013), the RhoGTPase Miro1 (Wang et al. 2011), and the inner membrane-resident mitochondrial protease HtrA2/Omi (Plun-Favreau et…”
BackgroundMitochondrial alterations in Parkinson’s disease: new clues
Vila, M., Ramonet, D., & Perier, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05604.x · Cited by 131
PINK1-Parkin Pathway Activity Is Regulated by Degradation of PINK1 in the Mitochondrial Matrix
Thomas, R. E., Andrews, L. A., Burman, J. L., Lin, W.-Y., & Pallanck, L. J. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004279 · Cited by 130
“studies concluding that PINK1 does not localize to the mitochondrial matrix [38,39].”
BackgroundMitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells
Rasola, A., Neckers, L., & Picard, D. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.03.005 · Cited by 129
Pilsl, A., & Winklhofer, K. F. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0902-3 · Cited by 139
Costa, A. C., Loh, S. H. Y., & Martins, L. M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2012.205 · Cited by 129
“oxidative stress, TRAP1 is phosphorylated in a PINK1dependent manner, and this phosphorylation is necessary to confer resistance to apoptosis.(10)”
BackgroundInfluentialAngeles, D. C., Gan, B.-H., Onstead, L., Zhao, Y., Lim, K.-L., Dachsel, J., Melrose, H., Farrer, M., Wszolek, Z. K., Dickson, D. W., et al. (2011) · Human Mutation · doi:10.1002/humu.21582 · Cited by 129
“…activity, had lost its ability to protect against dopamine-induced oxidative stress, while mutation in the catalytic region of PTEN induced putative kinase 1 (PINK1) resulted in impaired kinase activity on Hsp75 and protection against oxidative stress [Jiang et al., 2004; Pridgeon et al., 2007].”
BackgroundLeav, I., Plescia, J., Goel, H. L., Li, J., Jiang, Z., Cohen, R. J., Languino, L. R., & Altieri, D. C. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090521 · Cited by 133
“Most epithelial malignancies, including prostate cancer, exhibit a higher anti-apoptotic threshold, which contributes to disease progression.21 However, how this pro- cess is regulated, especially with respect to mitochondrial integrity, has remained largely unknown.9 The data presented here support a recent model tha…”
BackgroundOverexpression of Mitochondrial Hsp70/Hsp75 Protects Astrocytes against Ischemic Injury in vitro
Voloboueva, L. A., Duan, M., Ouyang, Y., Emery, J. F., Stoy, C., & Giffard, R. G. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600600 · Cited by 138
“It has been shown recently that, apart from serving as a mitochondrial molecular chaperone and binding partner for several mitochondrial enzymes, Hsp75 is directly involved in suppression of oxidant-induced cytochrome c release from mitochondria (Pridgeon et al, 2007).”
BackgroundBeyond the mitochondrion: cytosolic PINK 1 remodels dendrites through Protein Kinase A
Dagda, R. K., Pien, I., Wang, R., Zhu, J., Wang, K. Z. Q., Callio, J., Banerjee, T. D., Dagda, R. Y., & Chu, C. T. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12494 · Cited by 121
Wang, H., Chou, A.-H., Wu, A.-S., Chen, S.-Y., Weng, Y.-H., Kao, Y.-C., Yeh, T., Chu, P., & Lu, C.-S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.03.007 · Cited by 133
“A previous study reported that PINK1 inhibits oxidative stress-induced apoptotic cell death by phosphorylating mitochondrial chaperone TRAP1 [15].”
BackgroundCytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1
Takatori, S., Ito, G., & Iwatsubo, T. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.10.019 · Cited by 119
PINK1 Kinase Catalytic Activity Is Regulated by Phosphorylation on Serines 228 and 402
Aerts, L., Craessaerts, K., De Strooper, B., & Morais, V. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.620906 · Cited by 118
Etiology and Pathogenesis of Parkinson Disease
Schapira, A. H. V. (2009) · Neurologic Clinics · doi:10.1016/j.ncl.2009.04.004 · Cited by 143
Xi, Y., Ryan, J., Noble, S., Yu, M., Yilbas, A. E., & Ekker, M. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07091.x · Cited by 128
“Over-expression of PINK1 in cell culture seems to protect neurons against mitochondrial dysfunction and apoptosis induced by stress (Plun-Favreau et al., 2007; Pridgeon et al., 2007).”
BackgroundHuang, E., Qu, D., Huang, T., Rizzi, N., Boonying, W., Krolak, D., Ciana, P., Woulfe, J., Klein, C., Slack, R. S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01435-1 · Cited by 111
Kinases and kinase signaling pathways: Potential therapeutic targets in Parkinson's disease
Wang, G., Pan, J., & Chen, S. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.003 · Cited by 124
“Several studies have reported the mitochondrial molecular chaperone tumor necrosis factor receptor-associated protein-1 (TRAP1) to be a substrate for PINK1 (Pridgeon et al., 2007).”
BackgroundInfluentialMitochondria Dysfunction and Neurodegenerative Disorders: Cause or Consequence
Morais, V. A., & De Strooper, B. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100345 · Cited by 111
“This argument was validated by the identification of three PINK1 mitochondrial substrates, i.e., the mitochondrial heat shock protein TRAP1, the proapoptotic protein Htr2a/OMI [74,75],and, more recently, Parkin [76].”
BackgroundCosta, C. A. D., Manaa, W. E., Duplan, E., & Checler, F. (2020) · Cells · doi:10.3390/cells9112495 · Cited by 110
Grünewald, A., Gegg, M. E., Taanman, J.-W., King, R. H., Kock, N., Klein, C., & Schapira, A. H. V. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.027 · Cited by 102
“PINK1 was previously reported to function in the response to cellular stress (Pridgeon et al., 2007; Wang et al., 2007).”
The Yeast Complex I Equivalent NADH Dehydrogenase Rescues pink1 Mutants
Vilain, S., Esposito, G., Haddad, D., Schaap, O., Dobreva, M. P., Vos, M., Van Meensel, S., Morais, V. A., De Strooper, B., & Verstreken, P. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002456 · Cited by 110
“While Pink1 likely acts via multiple (phospho-) targets [41,42], our data suggests a pathway in which many of the deficiencies in pink1 can be traced back to mitochondrial dysfunction [8–10,15].”
BackgroundWang, K., Zhou, L., Wang, J., Wang, Y., Sun, T., Zhao, B., Yang, Y.-J., An, T., Long, B., Li, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms8619 · Cited by 111
TRAP1 rescues PINK1 loss-of-function phenotypes
Zhang, L., Karsten, P., Hamm, S., Pogson, J. H., Müller-Rischart, A. K., Exner, N., Haass, C., Whitworth, A. J., Winklhofer, K. F., Schulz, J. B., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt132 · Cited by 108
“Among the described functions, TRAP1 is thought to protect from apoptosis induced by diverse stressors like oxidants (21).”
BackgroundInfluentialBenjelloun, B., Alberto, F. J., Streeter, I., Boyer, F., Coissac, É., Stucki, S., Benbati, M., Ibnelbachyr, M., Chentouf, M., Bechchari, A., et al. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00107 · Cited by 128
The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease
Camilleri, A., & Vassallo, N. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12264 · Cited by 105
“Most investigations have shown that PINK1 attaches to the inner mitochondrial membrane, while others propose that PINK1 localizes to the intermembrane space [82,83].”
BackgroundMitochondrial Respiratory Dysfunction in Familiar Parkinsonism Associated with PINK1 Mutation
Piccoli, C., Sardanelli, A. M., Scrima, R., Ripoli, M. C., Quarato, G., D’Aprile, A., Bellomo, F., Scacco, S., Michele, G. D., Filla, A., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9729-2 · Cited by 109
“As mentioned in the introduction, defective phosphorylation by the mutated PINK1 kinase of the mitochondrial chaperone TRAP1 [12] can abrogate a protective effect exerted by this protein in preventing cytochrome c release from mitochondria [12, 30, 31].”
BackgroundInfluentialL-Arginine and Nitric Oxide in CNS Function and Neurodegenerative Diseases
Virarkar, M., Alappat, L., Bradford, P. G., & Awad, A. B. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.573885 · Cited by 104
“, 2003), PTEN-induced putative kinase 1 (PINK1) (Pridgeon et al., 2007), and tyrosine hydroxylase have been found in the brains of PD patients (Murray et al.”
BackgroundKang, B. H., Siegelin, M. D., Plescia, J., Raskett, C. M., Garlick, D. S., Dohi, T., Lian, J. B., Stein, G. S., Languino, L. R., & Altieri, D. C. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1818 · Cited by 104
Unravelling mitochondrial pathways to Parkinson's disease
Celardo, I., Martins, L. M., & Gandhi, S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12433 · Cited by 103
“, 2007) and phosphorylation of mitochondrial chaperone receptor-associated protein 1 (TRAP1; Pridgeon et al., 2007), to eliminate misfolded proteins and to restore damaged mitochondria.”
BackgroundWoodroof, H. I., Pogson, J. H., Begley, M., Cantley, L. C., Deak, M., Campbell, D. G., van Aalten, D. M. F., Whitworth, A. J., Alessi, D. R., & Muqit, M. M. K. (2011) · Open Biology · doi:10.1098/rsob.110012 · Cited by 103
“Pridgeon JW, Olzmann JA, Chin LS, Li L. 2007 PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.”
BackgroundInfluentialFunction and Characteristics of PINK1 in Mitochondria
Matsuda, S., Kitagishi, Y., & Kobayashi, M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/601587 · Cited by 102
“Adding to the variety of survival functions of PINK1, it has been shown to phosphorylate the mitochondrial heat shock protein 75 kDa (TRAP1), increasing neuronal survival against oxidative stress or heat shock by preventing the release of cytochrome c [19].”
BackgroundDagda, R. K., & Chu, C. T. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9255-1 · Cited by 102
“Overexpression of wild-type PINK1 in SH-SY5Y neuroblastoma cells stabilizes respiring mitochondrial networks through various mechanisms that include maintaining mitochondrial membrane potential, reducing basal and neurotoxin-induced ROS, suppression of cytochrome c release, reversal of toxin-induced fission, and suppr…”
BackgroundXiong, N., Huang, J., Chen, C., Zhao, Y. Y., Zhang, Z., Jia, M., Zhang, Z., Hou, L., Yang, H., Cao, X., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.007 · Cited by 107
“Oxidative stress, which occurs when the generaion of ROS in a system exceeds the system’s ability to deal ith, is 1 of the key pathophysiological mechanisms in PD Battisti et al., 2008; Pridgeon et al., 2007; Testa et al., 005; Veech et al., 2000; Xiong et al., 2009; Zhang et al., 000).”
BackgroundThe mitochondrial kinase PINK 1: functions beyond mitophagy
Voigt, A., Berlemann, L. A., & Winklhofer, K. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13655 · Cited by 108
Masgras, I., Ciscato, F., Brunati, A. M., Tibaldi, E. V., Indraccolo, S., Curtarello, M., Chiara, F., Cannino, G., Papaleo, E., Lambrughi, M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.056 · Cited by 103
BAG2 structure, function and involvement in disease
Qin, L., Guo, J., Zheng, Q., & Zhang, H. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0020-2 · Cited by 98
“Pridgeon JW, Olzmann JA, Chin LS, Li L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.”
Genetic determinants at the interface of cancer and neurodegenerative disease
Morris, L. G. T., Veeriah, S., & Chan, T. A. (2010) · Oncogene · doi:10.1038/onc.2010.127 · Cited by 98
“A key role of PINK1 is to phosphorylate TRAP1, a mitochondrial molecular chaperone with anti-apoptotic function, preventing release of mitochondrial cytochrome c in cases of oxidative stress (Pridgeon et al., 2007).”
The Miro GTPases: At the heart of the mitochondrial transport machinery
Reis, K., Fransson, Å., & Aspenström, P. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.04.015 · Cited by 97
“PINK1 has been shown to have a role in cellular protection against oxidative stress [54] and to affect mitochondrial dynamics and morphology in cooperation with mitochondrial fusion/fission proteins [55].”
BackgroundHatano, T., Kubo, S., Sato, S., & Hattori, N. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06403.x · Cited by 118
Feng, C., Wen, Z., Huang, S., Hung, H.-C., Chen, C., Yang, S., Chen, N., Wang, H., Hsiao, C., & Chen, W.-F. (2014) · Zebrafish · doi:10.1089/zeb.2013.0950 · Cited by 112
“Some studies have demonstrated that the overexpression of pink1 helps protect against stress caused by mitochondrial defects and apoptotic processes.(49,50) Exner et al.”
PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease
Mouton-Liger, F., Jacoupy, M., Corvol, J.-C., & Corti, O. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00120 · Cited by 96
“Finally, early studies linked PINK1 with phosphorylation of the mitochondrial chaperone, tumor necrosis factor (TNF) receptor-associated protein TRAP1, (Pridgeon et al., 2007) and the mitochondrial intermembrane space serine protease, HtrA2 (Plun-Favreau et al.”
Guzzo, G., Sciacovelli, M., Bernardi, P., & Rasola, A. (2014) · Oncotarget · doi:10.18632/oncotarget.2472 · Cited by 105
“Moreover, TRAP1 is a phosphorylation target of the Ser/ Thr kinase PINK1 [26] and of the Tyr kinase Src [42], and it is reported to be both phosphorylated and acetylated in public databases [15]; therefore, it can be envisioned that post-translational modifications might further affect TRAP1 modulation of SDH enzymati…”
Lourenço, C. F., Ledo, A., Barbosa, R. M., & Laranjinha, J. A. N. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.026 · Cited by 107
“Evidence of altered NO bioactivity is afforded by the observation of increased nitration and oxidation products in post mortem brains of patients with PD [165], namely nitration of α-synuclein [166]; detection of S-nitrosation of key proteins in the context of PD such as parkin [167], PTEN-induced putative kinase 1 (P…”
BackgroundDJ-1 protects against dopamine toxicity
Lev, N., Ickowicz, D., Barhum, Y., Lev, S., Melamed, E., & Offen, D. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0134-4 · Cited by 96
“Furthermore, a recently published study reported that another gene linked to inherited PD, PINK1, phosphorylates the downstream effector TRAP1 to prevent oxidative-stress-induced apoptosis (Pridgeon et al. 2007).”
BackgroundFitzgerald, J. C., Zimprich, A., Carvajal Berrio, D. A., Schindler, K. M., Maurer, B., Schulte, C., Bus, C., Hauser, A.-K., Kübler, M., Lewin, R., et al. (2017) · Brain · doi:10.1093/brain/awx202 · Cited by 96
“TRAP1 and HTRA2 are targets of the Parkinson’s disease kinase PINK1 (Plun-Favreau et al., 2007; Pridgeon et al., 2007).”
BackgroundYamashita, K., Miyata, H., Makino, T., Masuike, Y., FURUKAWA, H., Tanaka, K., Miyazaki, Y., Takahashi, T., Kurokawa, Y., Yamasaki, M., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6096-8 · Cited by 96
Cloutier, P., & Coulombe, B. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.02.010 · Cited by 108
Martin, S. A., Hewish, M., Sims, D., Lord, C. J., & Ashworth, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2836 · Cited by 94
“Over-expression of PINK1 protects cells from apoptosis in response to oxidative stress such as H202 and suppresses cytochrome c relesase from the mitochondria (15).”
BackgroundInfluentialMitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease
Trancikova, A. K., Tsika, E., & Moore, D. J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4200 · Cited by 100
“TRAP1 is a mitochondrial chaperone that is phosphorylated by PINK1 in cellular models.”
InfluentialBiochemical aspects of the neuroprotective mechanism of PTEN‐induced kinase‐1 (PINK1)
Mills, R. D., Sim, C. H., Mok, S. S., Mulhern, T. D., Culvenor, J. G., & Cheng, H. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05249.x · Cited by 93
“In rat brain, PINK1 is detected in both the mitochondrial inner and outer membrane preparations (Gandhi et al. 2006) while recombinant PINK1 was found to be localized in the mitochondrial intermembrane space of human embryonic kidney 293 cells (Pridgeon et al. 2007).”
BackgroundInfluentialHsp90 inhibitors as senolytic drugs to extend healthy aging
Fuhrmann-Stroissnigg, H., Niedernhofer, L. J., & Robbins, P. D. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1475828 · Cited by 92
“Other Trap1 client proteins include the kinase PINK1 [75] which protects against oxidative stress, the Ca binding protein sorcin [86], and the cytoprotective protein kinase BRAF [87].”
BackgroundThe mitochondrial permeability transition pore and its adaptive responses in tumor cells
Rasola, A., & Bernardi, P. (2014) · Cell Calcium · doi:10.1016/j.ceca.2014.10.003 · Cited by 91
Genes associated with Parkinson syndrome
Biskup, S., Gerlach, M., Kupsch, A. R., Reichmann, H., Riederer, P. F., Vieregge, P., Wüllner, U., & Gasser, T. (2008) · Journal of Neurology · doi:10.1007/s00415-008-5005-2 · Cited by 103
“PS linked mutations within PINK1 impair its protective activity [63].”
BackgroundKill one or kill the many: interplay between mitophagy and apoptosis
Wanderoy, S., Hees, J. T., Klesse, R., Edlich, F., & Harbauer, A. B. (2020) · Biological Chemistry · doi:10.1515/hsz-2020-0231 · Cited by 98
Redox mechanisms in age-related lung fibrosis
Kurundkar, A., & Thannickal, V. J. (2016) · Redox Biology · doi:10.1016/j.redox.2016.06.005 · Cited by 97
“AECs in IPF lung show evidence of mitochondrial dysfunction characterized by low expression of PTEN-induced putative kinase 1(PINK1) protein [76], a key protective mechanism by promoting mitophagy in response to oxidative stress [79,80].”
BackgroundHaque, M. E., Mount, M. P., Safarpour, F., Abdel-Messih, E., Callaghan, S., Mazerolle, C., Kitada, T., Slack, R. S., Wallace, V., Shen, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.346437 · Cited by 84
“Pink1 can phosphorylate two mitochondrial proteins, Trap1 and HtrA2 (11, 12).”
Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish
Sallinen, V. J., Kolehmainen, J., Priyadarshini, M., Toleikyte, G., Chen, Y., & Panula, P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.001 · Cited by 101
“A few targets for PINK1 have been identified: TNF receptor-associated protein 1, which protects against oxidative stress (Pridgeon et al., 2007), and Drp1, which promotes mitochondrial fission (Park et al., 2009; Poole et al., 2008).”
BackgroundGenetic mutations and functions of PINK1
Kawajiri, S., Saiki, S., Sato, S., & Hattori, N. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.06.001 · Cited by 101
Mitochondrial quality control and neurological disease: an emerging connection
de Castro, I. P., Martins, L. M., & Tufi, R. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001456 · Cited by 86
Joshi, A., Dai, L., Liu, Y., Lee, J., Ghahhari, N. M., Segala, G., Beebe, K., Jenkins, L. M., Lyons, G. C., Bernasconi, L., et al. (2020) · BMC Biology · doi:10.1186/s12915-020-0740-7 · Cited by 84
“Pridgeon JW, Olzmann JA, Chin LS, Li L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.”
Mitochondrial dynamics, cell death and the pathogenesis of Parkinson’s disease
Büeler, H. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0465-0 · Cited by 94
“These are the mitochondrial protease HtrA2 [144], the mitochondrial chaperone TRAP1 (Hsp75) [142] and Parkin [145].”
DJ‐1, PINK1, and their effects on mitochondrial pathways
Cookson, M. (2010) · Movement Disorders · doi:10.1002/mds.22713 · Cited by 92
“The mitochondrial chaperone TRAP1 has been proposed as a relevant substrate in one study.(64) Very recently, the mitochondrial protease and inhibitor of apoptosis, Omi, has been suggested to be phosphorylated in a PINK1dependent manner although whether it is a direct PINK1 substrate is unclear.”
BackgroundPathogenesis of Parkinson's disease: emerging role of molecular chaperones
Bandopadhyay, R., & de Belleroche, J. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.11.004 · Cited by 92
Molecular Insights into Parkinson's Disease
Rochet, J., Hay, B. A., & Guo, M. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00011-4 · Cited by 96
Mitochondrial Protein Targets of Thiol-Reactive Electrophiles
Wong, H. L., & Liebler, D. C. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700433m · Cited by 83
Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration
Nakamura, T., Oh, C.-K., Zhang, X., & Lipton, S. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.002 · Cited by 88
Regulation of parkin and PINK1 by neddylation
Choo, Y. S., Vogler, G., Wang, D., Kalvakuri, S., Iliuk, A. B., Tao, W. A., Bodmer, R., & Zhang, Z. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds070 · Cited by 88
Targeting mitochondrial dysfunction in neurodegenerative disease: Part II
Burchell, V. S., Gandhi, S., Deas, E., Wood, N. W., Abramov, A. Y., & Plun-Favreau, H. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003730434 · Cited by 82
“Expression of the mitochondrial heat shock protein hsp70 is also decreased in PD brains and in a cellular model of PD [55], and phosphorylation of the mitochondrial chaperone TNF-associated protein 1 (TRAP1, also called hsp75) by PINK1 has been shown to protect against oxidative stress [56].”
BackgroundCell Death Pathways in Parkinson's Disease: Role of Mitochondria
Yao, Z., & Wood, N. W. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2624 · Cited by 80
“Most reports have indicated that PINK1 localizes subcellularly in the inner membrane of mitochondria (41, 122, 136), the mitochondrial intermembrane space (122, 136), and=or the outer mitochondrial membrane (41, 178).”
Pink1 suppresses α-synuclein-induced phenotypes in a Drosophila model of Parkinson’s disease
Todd, A. M., & Staveley, B. E. (2008) · Genome · doi:10.1139/g08-085 · Cited by 92
Amo, T., Sato, S., Saiki, S., Wolf, A. M., Toyomizu, M., Gautier, C. A., Shen, J., Ohta, S., & Hattori, N. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.027 · Cited by 78
“Loss of PINK1 function induces increased vulnerability to various stresses (Exner et al., 2007; Haque et al., 2008; Pridgeon et al., 2007; Wood-Kaczmar et al., 2008).”
Molecular pathogenesis of Parkinson's disease: update
Saiki, S., Sato, S., & Hattori, N. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301205 · Cited by 105
Corti, O., & Brice, A. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.11.002 · Cited by 85
“How then is the fragment released into the cytosol to be degraded? Regardless of its submitochondrial localization, is the fast turnover of PINK1 compatible with any hypothesized protective functions [18,21]?”
Unfolded protein stress in the endoplasmic reticulum and mitochondria: a role in neurodegeneration
Bernales, S., Soto, M. M., & McCullagh, E. (2012) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2012.00005 · Cited by 78
PINK1 in the limelight: multiple functions of an eclectic protein in human health and disease
Arena, G., & Valente, E. M. (2017) · The Journal of Pathology · doi:10.1002/path.4815 · Cited by 78
“PINK1-mediated phosphorylation of TRAP1 protects mitochondria against oxidative stress-induced apoptosis [36].”
BackgroundGao, D., Wu, M.-F., Wang, C., Wang, Y., & Zuo, Z. (2015) · Aquatic Toxicology · doi:10.1016/j.aquatox.2015.08.013 · Cited by 82
TRAP1 Regulates Proliferation, Mitochondrial Function, and Has Prognostic Significance in NSCLC
Agorreta, J., Hu, J., Liu, D., Delia, D., Turley, H., Ferguson, D. J. P., Iborra, F. J., Pajares, M. J., Larráyoz, M., Zudaire, I., et al. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0481 · Cited by 78
“TRAP1 is mainly localized in mitochondria of normal and tumor cells (4, 5) acting as a substrate for the serine/threonine kinase PINK1 (6).”
BackgroundKang, B.-H. (2012) · BMB Reports · doi:10.5483/bmbrep.2012.45.1.1 · Cited by 74
“Phosphorylation of TRAP1 by PTEN induced putative kinase 1 (PINK1) is responsible for the protection of ROS mediated cell death (42).”
BackgroundProtective Role of Heat Shock Proteins in Parkinson’s Disease
Aridon, P., Geraci, F., Turturici, G., D’Amelio, M., Savettieri, G., & Sconzo, G. (2011) · Neurodegenerative Diseases · doi:10.1159/000321548 · Cited by 82
Molecular basis of Parkinson's disease
Yang, Y. X., Wood, N. W., & Latchman, D. S. (2009) · Neuroreport · doi:10.1097/wnr.0b013e32831c50df · Cited by 76
Metadata
- Authors
- Pridgeon, J. W., Olzmann, J. A., Chin, L.-S., & Li, L.
- Affiliations
- Emory University (US)
- Corresponding author
- Chin, Lih-Shen
- Li, Lian
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-06-19
- Volume
- 5
- Issue
- 7
- Pages
- e172
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC1892574
- OpenAlex
- W2055538245
- Cited by
- 596
- References
- 44
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 11 · 2023: 11 · 2022: 20 · 2021: 29 · 2020: 27 · 2019: 14 · 2018: 25 · 2017: 30 · 2016: 21 · 2015: 36 · 2014: 39 · 2013: 39 · 2012: 45
- FWCI
- 42.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute on Aging (AG021489, R01AG021489)
- National Institute of Neurological Disorders and Stroke (F31NS054597, NS-047199, R01NS047199, NS050650, R01NS050650)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- PINK1, TRAP1, Parkinson's disease, oxidative stress, mitochondrial chaperone, protein phosphorylation, cytochrome c release, apoptosis, PINK1 mutations, neurodegeneration
- MeSH terms
- PTEN-Induced Putative Kinase, Animals, Base Sequence, HeLa Cells, Humans, Mitochondria, Phosphorylation, Protein Binding, Protein Kinases, Recombinant Proteins, Substrate Specificity, Transfection, PC12 Cells, Apoptosis, Point Mutation, Oxidative Stress, HSP90 Heat-Shock Proteins, Parkinsonian Disorders, RNA, Small Interfering, Cytochromes c, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.